CD274 and neoplasm: PD-L1 expression in non-invasive neoplasms has been explored in parallel with its invasive counterparts, suggesting that immune evasion by PD-L1 starts early in dysplastic lesions and becomes more prominent with the achievement of the invasive phenotype [51].